Skip To Main Content
Yingduo Song on Muck Rack

Yingduo Song

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingduo

Contact Yingduo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial | Nature Communications

|
By Tim Kong, Alex Mabry, Mateusz Opyrchal, Foluso O Ademuyiwa, Ian Hagemann, Stephen T. Oh, Jianxin Wang, Erik S. Knudsen, Ron Bose, Jason Weber, Jingqin Luo, Yingduo Song, Wenge Zhu
| Nature Verified
Abstract CDK4/6 inhibitors (CDK4/6i) improve outcomes for estrogen receptor (ER) positive/HER2-negative breast cancers (BCs), yet intrinsic and acquired resistance exist. Here, we evaluated anastrozole in combination with palbociclib (ANA/PAL) in the NeoPalAna Endocrine-Resistant cohort (NCT01723774).
Open in Who Shared Issue with article?
See all 1 articles